Cognitive Remediation in Early Phase Psychosis

March 1, 2012 updated by: Oslo University Hospital
The purpose of the study is to investigate the effect of a 30 hour cognitive remediation program for young patients with early phase schizophrenia spectrum disorders on cognitive, clinical and functional outcome measures. The remediation program is integrated with whatever active rehabilitation the participant is currently attending (school, work, day program etc).

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Oslo, Norway, 0407
        • Recruiting
        • Psychosis Research Unit, Division of Mental Health and Addiction, Oslo University Hospital.
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Early phase schizophrenia, schizoaffective disorder, psychosis NOS
  • Less than 5 years since start of adequate treatment for psychotic disorder
  • Age between 18-40
  • Norwegian speaking (sufficiently to understand and complete assessments)

Exclusion Criteria:

  • Traumatic brain injury
  • Neurological disorder as determined by medical history
  • IQ below 70

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cognitive remediation
30 hour computer based cognitive remediation integrated in participants current rehabilitation program (school, work, day program)
Cognitive remediation including feedback from neurocognitive assessment, psychoeducation about cognitive deficits, 30 hours of computer based drill and practise and strategy coaching based cognitive remediation, 1-3 collaborative meetings with cognitive specialist, participant, therapist and teacher, occupational therapist or other therapist (depending on participants rehabilitation situation) to enhance transfer of skills to daily functioning
NO_INTERVENTION: Wait list control group
Participant continues in treatment/rehabilitation program as usual until 9 month assessment when participant receives the same cognitive remediation program as the experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MATRICS Consensus Cognitive Battery (MCCB)
Time Frame: Change in MCCB performance from baseline to 4 months and 9 months
Included in the MCCB are measures of the following cognitive domains: Speed of Processing, Attention, Working memory, Verbal learning, Visual Learning, Reasoning and problem solving and Social Cognition. In addition the following tests are included: HVLT-R and BVMT-R delayed recall to measure memory, TMTB (Halstead Reitan) and Color Word Inteference Test (D-KEFS) to measure executive functioning), Digit span (WAIS-III)to measure working memory, Grooved Pegboard (Halstead Reitan) to measure motor function.
Change in MCCB performance from baseline to 4 months and 9 months
UCSD Performance Based Skilled Assessment Brief Version (UPSA-B)
Time Frame: Change in UPSA-B performance from baseline to 4 months and 9 months
Change in UPSA-B performance from baseline to 4 months and 9 months
Cognitive Assessment Interview (CAI)
Time Frame: Change in CAI scores from baseline to 4 months and 9 months
Change in CAI scores from baseline to 4 months and 9 months
Social Functioning Scale (SFS)
Time Frame: Change in SFS scores from baseline to 4 months and 9 months
Change in SFS scores from baseline to 4 months and 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calgary Depression Scale
Time Frame: Change in CDS scores from baseline to 4 months and 9 months
Change in CDS scores from baseline to 4 months and 9 months
Global Assessment of Function (GAF)- split version
Time Frame: Change in GAF scores from baseline to 4 months and 9 months
Change in GAF scores from baseline to 4 months and 9 months
event related fMRI
Time Frame: Change in BOLD fMRI signal from baseline to 4 months
Event-related fMRI will be performed to measure neuronal activity during a spatial working memory tasks and an executive planning task. All fMRI data will be collected on Ullevål's 3 T General Electric Sigma HDx scanner.
Change in BOLD fMRI signal from baseline to 4 months
Rosenberg Self-Esteem Scale (RSES)
Time Frame: Change in RSES scores from baseline to 4 months and 9 months
Change in RSES scores from baseline to 4 months and 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Torill Ueland, PhD, Psychosis Research Unit, Division of Mental Health and Addiction, Oslo University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (ANTICIPATED)

December 1, 2013

Study Completion (ANTICIPATED)

December 1, 2013

Study Registration Dates

First Submitted

January 12, 2012

First Submitted That Met QC Criteria

March 1, 2012

First Posted (ESTIMATE)

March 7, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

March 7, 2012

Last Update Submitted That Met QC Criteria

March 1, 2012

Last Verified

March 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Cognitive remediation

3
Subscribe